Safety and Efficacy of Fruquintinib Plus Nab-Paclitaxel and Iparomlimab and Tuvonralimab Injection in the Second-Line Treatment for Immunotherapy-experienced Advanced Gastric Cancer
Abroad (travel likely)RecruitingPHASE2
Conditions
Gastric Cancer Adenocarcinoma Metastatic
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Chinese PLA General Hospital, Beijing, Beijing, Beijing Municipality, China